HIGH-RISK PCI, MCS SUPPORT, AND BIFURCATIONS

Monday, March 10, 2025

8:00 AM - 9:55 AM ET

Moderator(s)

Antonio Colombo, MD

Professor of Cardiology
Humanitas IRCCS
Milan, Lombardia, Italy

No relationships to disclose
David E. Kandzari, MD, FACC, FSCAI

Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States

No relationships to disclose

Disclosure(s):

Antonio Colombo, MD: No financial relationships to disclose

David E. Kandzari, MD, FACC, FSCAI: Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Ablative Solutions, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); DeepQure: Consulting Fees (e.g., advisory boards) (Ongoing); GoldenLeaf Medical: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Supira Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)